Cite
MLA Citation
Hui Gan et al.. “ATIM-23. PRELIMINARY FINDINGS OF A PHASE I SAFETY AND BIOIMAGING TRIAL OF KB004 (IFABOTUZUMAB) IN PATIENTS WITH GLIOBLASTOMA.” Neuro-oncology, vol. 21, n.d., p. vi6. http://access.bl.uk/ark:/81055/vdc_100101669248.0x000045